Lorrane Davi Brito de Toledo

Lorrane Davi Brito de Toledo

Auto-generated profile, based on publicly available information

Lorrane Davi Brito de Toledo

Universidade Estadual Paulista

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in Journal of Toxicology and Environmental Health, Part A
Verified
Journal Article
Closed access
LBLorrane Davi Brito
Lorrane Davi Brito
CACaroline de Souza Araujo
Caroline de Souza Araujo
DCDalita Gomes Silva Moraes Cavalcante
Dalita Gomes Silva Moraes Cavalcante
AGAndressa Silva Gomes
Andressa Silva Gomes
MZMarcos Alberto Zocoler
Marcos Alberto Zocoler
LKLeandra Ernst Kerche
Leandra Ernst Kerche
Medicinal plants have always been used for therapeutic purposes; however, some plants may contain toxic and mutagenic substances. The aim of this study was to assess the cytotoxic, genotoxic, mutagenic, antioxidant, antigenotoxic, and antimutagenic effects of the bark ethanolic extract of Spondias purpurea L. using male and female Swiss albino mice. To determine the protective effects of the extract, benzo[a]pyrene (B[a]P) and cyclophosphamide (CP) were selected as cell damage inducers. The extract was examined at doses of 500, 1000, or 1500 mg/kg body weight (BW)via gavage alone or concomitant with B[a]P or CP. Oxidative stress was measured by quantification of blood catalase activity (CAT), reduced glutathione (GSH) levels in total blood, liver, and kidney, and concentrations of malondiadehyde (MDA) in liver and kidney. Genotoxicity and antigenotoxicity were evaluated by the comet assay using peripheral blood. Cytotoxicity, mutagenicity, and antimutagenicity were determined utilizing the micronucleus test in bone marrow and peripheral blood. The S. purpurea L extract increased CAT activity and GSH levels accompanied by a decrease in MDA levels after treatment with B[a]P and CP. No genotoxic, cytotoxic, or mutagenic effects were found in mice exposed only to the extract. These results indicate that the extract of S. purpurea exhibited protective effects against oxidative and DNA damage induced by B[a]P and CP.

25 March 2025 in Revista Fitos
Verified
Journal Article
Open access
RLRute Lopes
Rute Lopes
LTLorrane Davi Brito de Toledo
Lorrane Davi Brito de Toledo
ERElisandra Márcia Rodrigues
Elisandra Márcia Rodrigues
AGAna Maria Minarelli Gaspar
Ana Maria Minarelli Gaspar
PCPaulo Inacio Da Costa
Paulo Inacio Da Costa
Natural bioactive compounds (NBCs) has been reported to possess antiviral and hepatoprotective effects, like curcumin (CL) and piperine (PP). Herein, we report a study of hepatitis C virus biosynthesis and its molecular mechanisms in human hepatocarcinoma cells, expressing or not the HCV (SGR-JFH1) when exposed to CL, PP and its association (CL/PP). Inhibiting concentration (IC50) to CL were 30,95 ± 1,05 µM for Huh-7.5 and 41,96 ± 1,02 µM for SGR-JFH1 cells. For PP, the IC50 were 165,4 ± 1,15 and 200,3 ± 1,05 µM for Huh-7.5 and SGR-JFH1, respectively. An decrease in Cl/PP IC50 were observed with 26,02 ± 1,05 µM for Huh-7.5 and 19,74 ± 1,02 µM for SGR-JFH1. CL and PP induced inhibition of apoptosis. CL treatment at IC20 caused a slight increase of AMPK-α phosphorylation pathway in SGR-JFH1. Caspase-3 was expressed in IC10, and the other pathways were inhibited. HCV cells exposed to PP showed stimulated phosphorylation of FoxO-3a, as well as of the Bax/Bcl-2 in both NBC concentrations. In the CL/PP treatment, the phosphorylation of Akt1 and the Bax/Bcl-2 were shown to be intensified in SGR-JFH1. This work provides a new insight to the control of hepatitis C, when exposure to CL and PP.